Journal of Antimicrobial Chemotherapy, Vol 39, 31-34, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
N Matsumura, S Minami and S Mitsuhashi
The in-vitro activity of T-5575, 2-carboxypenam, a new parenteral
antibiotic and its stability to beta-lactamases were compared with those of
ceftazidime and imipenem. The activity of T-5575 was equal or superior to
that of ceftazidime or imipenem against Gram-negative bacteria that
produced penicillinase with the exception of the enzyme OXA-1. Against
strains that produced Cephalosporinase and zinc- dependent beta-lactamase,
the activity of T-5575 was superior to that of ceftazidime or imipenem.
T-5575 was a poor substrate and had low affinity for beta-lactamases
produced by Citrobacter freundii, Enterobacter cloacae and Pseudomonas
aeruginosa. The activity of T-5575 was less influenced by the derepressed
production of chromosomal enzymes than that of ceftazidime. Overall, T-5575
had excellent activity against Gram-negative pathogens that produced
various types of beta-lactamases.
JOURNAL ARTICLE
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase
Episome Institute, Gunma, Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?